≥18 years HIV+, cART-naïve First CM Intensive Ampho 14 d Consolidation 400mg Fluconazole 12 weeks Maintenance 200mg Fluconazole therapy W02 W04 W08 W12.

Slides:



Advertisements
Similar presentations
Excellent healthcare – locally delivered What’s new in the diagnosis, prevention and management of HIV-related cryptococcal disease Nelesh Govender (on.
Advertisements

Levels of IL-18, sCD14, CCL2, CXCL8 and CXCL10 in tubercular immune reconstitution inflammatory syndrome in a North Indian population Manoj Kumar 1, Patricia.
OPPORTUNISTIC FUNGAL INFECTIONS
Impact of Active Tuberculosis on Immune Recovery in HIV-infected Individuals Receiving ART H.Y. Tan 1, Y.K. Yong 1, L.Y. Ong 1, Y.M. Lee 1, S.F.S. Omar.
Immune Reconstitution Inflammatory Syndrome (IRIS)
Lecture: HIV I.Motivation What can we learn when we apply evolutionary principles to our understanding of the of the HIV epidemic?? Can we use HIV to introduce.
Cryptococcosis in the Non-HIV Patient Kristen Amann, MD Morning Report August 12, 2009.
Cryptococcal Meningitis in Patients with AIDS. Clinical Case 30-year-old male with AIDS CD4 25 cells/mm3 Gradual increasing headache for past five days.
Blocviroc – an innovative treatment for HIV/AIDS Steve English Development Head, Antivirals.
J.L.K. Fletcher, S. Pinyakorn, M. de Souza, S. Akapirat, R. Trichavaroj, T. Pankam, E. Kroon, D. Colby, P. Prueksakaew, D. Suttichom, J.H. Kim, P. Phanuphak,
CASE 1 55 yo man…Baker HIV+ since 1996 Refused bloodwork over the years as was ‘Feeling fine’ Oral hairy leukoplakia noted on oral biopsy in 2001.
Plate 87 Acquired Immune Deficiency Syndrome (AIDS)
Antibody and B cell responses may control circulating lipopolysaccharide in patients with HIV infection Lim A 1, Amini A 1, D’Orsogna L 2, Rajasuriar R.
HIV and AIDS Are HIV and AIDS the same thing?. HIV HIV – Human Immunodeficiency Virus HIV – Human Immunodeficiency Virus A pathogen (virus) that destroys.
Cryptococcal Meningitis Dr N Thumbiran Infectious Diseases Department UKZN.
Prattana Leenasirimakul
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Association between CSF and peripheral markers of immune- activation/inflammation and elevated intratechal HIV–RNA levels in a cohort of.
1 An Interim Monitoring Approach for a Small Sample Size Incidence Density Problem By: Shane Rosanbalm Co-author: Dennis Wallace.
Switch to LPV/r monotherapy  Pilot LPV/r  M  LPV/r Mono  KalMo  OK  OK04  KALESOLO  MOST  HIV-NAT 077.
P1 Virology, Pathogenesis And Treatment Of HIV Infection.
Clinical and mycological determinants of Cryptococcosis-associated IRIS (C-IRIS) Chang CC, Elliott JE, Gosnell BI, Dorasamy AA, Omarjee S, Naranbhai V,
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
A 21-year-old man with rapidly deteriorating somnolence Neurology Resident and Fellow Section © 2013 American Academy of Neurology.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Cryptococcosis Slide Set Prepared by the AETC.
Why study evolution?  Best conceptual framework for understanding origins of biodiversity  Adaptations that allow organisms to exploit their environment.
Regulatory T cell abnormalities associated with aberrant CD4+ T-cell responses in HIV+ patients with immune reconstitution disease (IRD) Nabila SEDDIKI.
Enfuvirtide for Drug-Resistant HIV Infection in North and South America Simon R. Bababeygy.
Q1 Which of the following descriptions about HIV and TB interaction is right ? Which of the following descriptions about HIV and TB interaction is right.
Supplemental Fig. 1. Gating strategy to define Treg and iNKT cell subsets. (A) Representative scatter plots showing: the lymphocyte gate (R1), CD4+ cells.
Predictors of ART-associated TB in a prospective study: Results of the Kericho IRIS Study The Rainbow of IRIS in HIV Infection July 26, 2012 Fredrick.
Pp  HIV: human immunodeficiency virus  AIDS (acquired immune deficiency syndrome): weakened immune system caused by the infection of HIV HIV.
내과 R2 이지훈 N Engl J Med 2014;371:
TB-H V Co-infection by Dr. Ker Hong Bee 11. LEARNING OBJECTIVES To know & understand about TB-HIV co- infection in relation to:- – interaction & prevalence.
1 Chapter 35 HIV- and AIDS-Related Drugs Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.
Cryptococcal Meningitis (CM): Review of Treatment Guidance in Resource-Limited Settings (RLS) G. Gavriilidis, P. Easterbrook, L. Muhe, M. Vitoria Department.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
This presentation is intended for educational use only, and does not in any way constitute medical consultation or advice related to any specific patient.
Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal.
ART was initiated when indicated by WHO and national guidelines
coinciding with biphasic immune reconstitution
ART and toxicities: CNS
Implementing CRAG Screening among HIV Patients Initiating ART in Rural HIV Clinics with Regular Absence of CD4 Testing Services in Tanzania Gladys Mbwanji.
Immune dysregulation in HIV patients following successful ART Dino Tan, Yean Kong Yong, Hong Yien Tan, Adeeba Kamarulzaman, Lian Huat Tan, Andrew Lim,
Dr Dawood Quiz questions.
Cryptococcal Meningoencephalitis Nicole Wilde MD, MPH
Figure 4 Host damage from infection-related inflammatory
Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1–infected patients with immune reconstitution inflammatory syndrome by Yolanda.
Figure 2 Systemic immune responses to cryptococcal antigen
Cryptococcosis: Treatment outcome
Figure 2 Three-step approach to the assessment and management
Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis  A. Hedberg,
Nat. Rev. Neurol. doi: /nrneurol
Figure 5 Corticosteroid treatment can reduce brain
Cryptococcosis: Antifungal therapy management
Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study  S. Yan,
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Figure 1 Associations between baseline cerebrospinal fluid
Immune Reconstitution after Autologous Hematopoietic Cell Transplant (AHCT) in B-Cell Non-Hodgkin Lymphoma (B-NHL) Patients Mobilized with Granulocyte.
ئەيدىز كېسىلى (AIDS) مەمەتئىمىن دوكتۇر.
Cryptococcal Immune Reconstitution Inflammatory Syndrome
When to START During an OI
Volume 25, Issue 8, Pages (August 2017)
Cryptococcosis: Treatment outcome
Switch to LPV/r monotherapy
Volume 373, Issue 9672, Pages (April 2009)
Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.
Terminology HIV AIDS Acquired Human Immune Immunodeficiency Deficiency
Figure 3 DMF promotes an anti-inflammatory cytokine B-cell profile
Switch to LPV/r monotherapy
Presentation transcript:

≥18 years HIV+, cART-naïve First CM Intensive Ampho 14 d Consolidation 400mg Fluconazole 12 weeks Maintenance 200mg Fluconazole therapy W02 W04 W08 W12 W16 W20 W24 cART Neurological deterioration Probable C-IRIS Possible C-IRIS Not C-IRIS Blood CSF CD4+ T-cellsCD8+ T-cells CCR5 + FSC-ASSC-H CD8 + FSC-H CD3 + FSC-H CXCR3 + CD4 + GraphPad Prism  v5. FlowJo  v7.5. BD LSRII CD4 + and CD8 + T-cells co-expressing CXCR3 and CCR5 are increased in the cerebrospinal fluid relative to blood of HIV-infected patients with cryptococcal meningitis and associated with cryptococcal immune reconstitution inflammatory syndrome CC Chang, A Lim, S Omarjee, JH Elliott, BI Gosnell, WH Carr, MYS Moosa, T Ndung’u, SR Lewin, MA French d00 d14/W00 Poster WEPDA0104

Significantly higher proportions of CD4 + and CD8 + T-cells co-express CXCR3 and CCR5 in CSF than in blood CD4 + T-cellsCD8 + T-cells

Patients who developed probable/possible C-IRIS had significantly higher CSF/Blood ratios of CXCR3 + /CCR5 + CD4 + and CD8 + T-cells pre-cART commencement 40 patients with 52 ND events – categorised by 1 st ND event Probable C-IRIS2255.0% Possible C-IRIS717.5% Not C-IRIS1127.5%  CD4 + and CD8 + T em cells co-expressing CCR5 and CXCR3 are significantly enriched in CSF  Higher CSF/Blood ratios of CXCR3 + /CCR5 + CD4 + and CD8 + T cells pre- cART commencement predict the development of C-IRIS  Inhibitors of CXCR3 or CCR5 should be explored as preventative and therapeutic measures in C-IRIS Correspondence: